Toxicity of an Fc-Engineered Anti-Cd40 Antibody Is Abrogated by Intratumoral Injection and Results in Durable Antitumor Immunity

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1810566115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2002English

CD40/anti-CD40 Antibody Complexes Which Illustrate Agonist and Antagonist Structural Switches

BMC Molecular and Cell Biology
Cell BiologyMolecular Biology
2019English

Embryo Implantation Is Blocked by Intraperitoneal Injection With Anti-Lif Antibody in Mice

Journal of Reproduction and Development
Animal ScienceZoology
2011English

Effective Antibody Therapy Induces Host-Protective Antitumor Immunity That Is Augmented by TLR4 Agonist Treatment

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2011English

Antagonism of VEGF by Genetically Engineered Dendritic Cells Is Essential to Induce Antitumor Immunity Against Malignant Ascites

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

Delivery of NKG2D Ligand Using an Anti-Her2 Antibody-Nkg2d Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response

Cancer Research
Cancer ResearchOncology
2010English

Intratumoral Injection of an Adenovirus Expressing Interleukin 2 Induces Regression and Immunity in a Murine Breast Cancer Model.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

The Anti-Tumor Efficacy of 3C23K, a Glyco-Engineered Humanized Anti-Misrii Antibody, in an Ovarian Cancer Model Is Mainly Mediated by Engagement of Immune Effector Cells

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy